Wells Pharmacy Network
Recurring FDA findings since 2014, including a 616-product recall; most recent 2025 warning letteri has no closeout on file.
About this pharmacy
Legal entity: Wells Pharmacy Network, LLC
Facility type: 503A/503B — operates both a state-licensed compounding pharmacyi and an FDA-registered outsourcing facility.
The four standards
Holds PCABi accreditation.
FDA issued a warning letter on November 10, 2014, citing failure to receive valid patient-specific prescriptions. In September 2016, Wells recalledi 616 sterile products — all human and veterinary sterile products prepared over a seven-month period — due to lack of sterility assurance. In October 2025, FDA issued an untitled letteri following an April 2025 inspection finding FDCA violations. No closeout letteri has been found for the most recent action.
(Method: checked against FDA’s public warning-letter, untitled-letter, and recall databases.)
Source: FDA warning letter — November 2014
Operates under its stated legal name, not private-label branding.
At least one serious public complaint found (product cleanliness concerns, with an alleged resulting infection), treated as negative given severity, alongside otherwise limited public feedback.
(Method: assessed from patterns in public customer feedback; complaint not individually characterized beyond its general nature.)
Frequently asked questions
Is Wells Pharmacy Network accredited?
Yes. Wells Pharmacy Network holds PCAB accreditation.
Has Wells Pharmacy Network had any FDA regulatory actions?
Yes. FDA issued a warning letter on November 10, 2014, citing failure to receive valid patient-specific prescriptions. In September 2016, Wells recalled 616 sterile products — all human and veterinary sterile products prepared over a seven-month period — due to lack of sterility assurance. In October 2025, FDA issued an untitled letter following an April 2025 inspection finding FDCA violations. No closeout letter has been found for the most recent action. Checked against FDA’s public warning-letter, untitled-letter, and recall databases.